Terms: = Gastric cancer AND MPL, TPOR, P40238, 4352, ENSG00000117400, CD110, MPLV, C-MPL, RP1-92O14_1
46700 results:
1. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
[TBL] [Abstract] [Full Text] [Related]
2. Preoperatively predicting the lymph node metastasis and prognosis for gastric cancer patients.
Wang D; Wang Y; Dong L; Zhang X; Du J
Sci Rep; 2024 May; 14(1):11213. PubMed ID: 38755185
[TBL] [Abstract] [Full Text] [Related]
3. The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis.
Li JB; Lai MY; Lin ZC; Guan WL; Sun YT; Yang J; Wang WX; Yang ZR; Qiu MZ
Cancer Immunol Immunother; 2024 May; 73(7):132. PubMed ID: 38753055
[TBL] [Abstract] [Full Text] [Related]
4. Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants.
De la Torre K; Song M; Abe SK; Rahman MS; Islam MR; Saito E; Min S; Huang D; Chen Y; Gupta PC; Sawada N; Tamakoshi A; Shu XO; Wen W; Sakata R; Kim J; Nagata C; Ito H; Park SK; Shin MH; Pednekar MS; Tsugane S; Kimura T; Gao YT; Cai H; Wada K; Oze I; Shin A; Ahn YO; Ahsan H; Boffetta P; Chia KS; Matsuo K; Qiao YL; Rothman N; Zheng W; Inoue M; Kang D
J Diabetes; 2024 Jun; 16(6):e13561. PubMed ID: 38751364
[TBL] [Abstract] [Full Text] [Related]
5. Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer.
Han Z; Zhang Z; Yang X; Li Z; Sang S; Islam MT; Guo AA; Li Z; Wang X; Wang J; Zhang T; Sun Z; Yu L; Wang W; Xiong W; Li G; Jiang Y
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38749538
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced gastric cancer.
Yamaguchi K; Ito M; Isobe T; Koreishi S; Taguchi R; Uehara K; Ueno S; Imajima T; Kitazono T; Tsuchihashi K; Ohmura H; Yoshihiro T; Tanoue K; Nishiyori S; Iwama E; Maeda T; Akashi K; Baba E
JCO Precis Oncol; 2024 May; 8():e2300681. PubMed ID: 38748981
[TBL] [Abstract] [Full Text] [Related]
7. Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world data.
Egebjerg K; Andersen TS; Bæksgaard L; Garbyal R; Siemsen M; Achiam M; Mau-Sørensen PM
Acta Oncol; 2024 May; 63():322-329. PubMed ID: 38745482
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
9. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
Pang H; Dai L; Chen L; Chen X; Chen Z; Zhang S; Sun H
BMC Cancer; 2024 May; 24(1):583. PubMed ID: 38741082
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines.
Saeedi F; Salehi M; Kamali MJ; Mir MA; Kazemi S; Shirafkan F; Neyshaburi EZ; Moeeni R; Gorji N; Memariani Z
Med Oncol; 2024 May; 41(6):148. PubMed ID: 38733486
[TBL] [Abstract] [Full Text] [Related]
12. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
[TBL] [Abstract] [Full Text] [Related]
13. Extraction and Isolation of Two Polysaccharides from
Liu J; Li W; Jin L; Wang Y; Xu X; Ma E; Yang D; Zhao Z
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731534
[TBL] [Abstract] [Full Text] [Related]
14. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
[TBL] [Abstract] [Full Text] [Related]
15. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
[TBL] [Abstract] [Full Text] [Related]
16. Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer.
Liu Y; Chen W; Ruan R; Zhang Z; Wang Z; Guan T; Lin Q; Tang W; Deng J; Wang Z; Li G
J Transl Med; 2024 May; 22(1):438. PubMed ID: 38720336
[TBL] [Abstract] [Full Text] [Related]
17. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract] [Full Text] [Related]
18. Effects of perioperative low-dose naloxone on the immune system in patients undergoing laparoscopic-assisted total gastrectomy: a randomized controlled trial.
Min X; Ma Y; Leng Y; Li X; Zhang J; Xu S; Wang X; Lv R; Guo J; Xing H
BMC Anesthesiol; 2024 May; 24(1):172. PubMed ID: 38720250
[TBL] [Abstract] [Full Text] [Related]
19. Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway.
Lu Y; Wang H; Chen S; Yang B; Li Y; Li Y
J Cancer Res Clin Oncol; 2024 May; 150(5):244. PubMed ID: 38717526
[TBL] [Abstract] [Full Text] [Related]
20. The effect of self-designed metabolic equivalent exercises on cancer-related fatigue in patients with gastric cancer: A randomized controlled trial.
Xin X; Huang L; Pan Q; Zhang J; Hu W
Cancer Med; 2024 May; 13(9):e7085. PubMed ID: 38716637
[TBL] [Abstract] [Full Text] [Related]
[Next]